New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?

[ 23 ] reported a trend toward significance for a lower risk of PsA onset in patients with inverse psoriasis (OR 0.61, 95% CI 0.36–1.05, p -value 0.07), non-confirming literature data that reported an increased risk of PsA development in patients with scalp, nail, and inverse psoriasis [ 39 ].

also in 3,729 other papers

Patients Who Did Not Develop PsA No statistically significant difference was observed between new-onset PsA group and non-PsA group as regards ongoing treatments, nor was a significant trend between one drug or class of biologics and new-onset PsA risk observed.

also in 9,775 other papers